These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 14628164)

  • 21. Management of advanced abdominopelvic tumors with combined radiofrequency ablation and surgical debulking.
    Spiliotis J; Hadjicostas P; Rogdakis A; Vaxevanidou A; Malakounides N; Datsis A; Tsiveriotis K; Karkavitsa Z; Kekelos S
    Dig Surg; 2008; 25(3):188-90. PubMed ID: 18577862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
    Mahnken AH; Buecker A; Spuentrup E; Krombach GA; Henzler D; Günther RW; Tacke J
    J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of radiofrequency ablation therapy in patients with hepatic cavernous hemangiomas].
    Fan RF; Chai FL; He GX; Li RZ; Wan WX; Bai MD; Zhu WK; Cao ML; Li HM; Yan SZ
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1608-12. PubMed ID: 16185527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary assessment of utility of radiofrequency ablation technique in treatment of primary hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis.
    Witczak-Malinowska K; Zadrozny D; Studniarek M; Szurowska E; Michalska Z; Stalke P; Sikorska K; Lakomy EA
    Med Sci Monit; 2003 Aug; 9 Suppl 3():68-72. PubMed ID: 15156617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solitary colorectal liver metastasis: resection determines outcome.
    Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
    Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experience with radiofrequency ablation in the treatment of unresectable pelvic recurrence of rectal cancer].
    Mátrai Z; Fehér I; Péley G; Rényi Vámos F; Farkas E; Sulyok Z; Kovács T; Köves I
    Magy Seb; 2005 Feb; 58(1):21-7. PubMed ID: 16018597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiofrequency ablation of colorectal liver metastases].
    Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
    Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Painful pelvic recurrence of rectal cancer: percutaneous radiofrequency ablation treatment.
    Pusceddu C; Sotgia B; Melis L; Fele RM; Meloni GB
    Abdom Imaging; 2013 Dec; 38(6):1225-33. PubMed ID: 23736888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experience of radiofrequency ablation therapy for hepatocellular carcinoma].
    Iwauchi T; Yamada N; Amano R; Ohira M; Nishino H; Hirakawa K
    Gan To Kagaku Ryoho; 2005 Oct; 32(11):1663-5. PubMed ID: 16315902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
    Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
    Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
    Wang YH; Liu JF; Li F; Li A; Liu Q; Liu DB; Liu DG; Wang YJ
    Chin Med J (Engl); 2009 Apr; 122(8):889-94. PubMed ID: 19493409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.